245 related articles for article (PubMed ID: 34085164)
21. Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma With a High Tumor Mutational Burden and PD-L1 Expression by PD-1 Blockade Combined With Tyrosine Kinase Inhibitors: A Case Report.
Zhang Z; Zhang W; Wang H; Hu B; Wang Z; Lu S
Front Immunol; 2021; 12():744571. PubMed ID: 34603331
[TBL] [Abstract][Full Text] [Related]
22. Difficulty in differentiating between IgG4-related hepatic inflammatory pseudotumor and intrahepatic cholangiocarcinoma.
Hamano A; Yamada R; Kurata K; Tsuboi J; Inoue H; Tanaka K; Horiki N; Takei Y
Clin J Gastroenterol; 2021 Feb; 14(1):263-268. PubMed ID: 33037585
[TBL] [Abstract][Full Text] [Related]
23. Combined treatment of nonresectable cholangiocarcinoma complicated by obstructive jaundice.
Shiryaev AA; Musaev GK; Levkin VV; Reshetov IV; Loshchenov MV; Alekseeva PM; Volkov VV; Linkov KG; Makarov VI; Shchekoturov IO; Borodkin AV; Loschenov VB
Photodiagnosis Photodyn Ther; 2019 Jun; 26():218-223. PubMed ID: 30965145
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: Results of a pilot study.
Prat F; Lafon C; De Lima DM; Theilliere Y; Fritsch J; Pelletier G; Buffet C; Cathignol D
Gastrointest Endosc; 2002 Dec; 56(6):909-15. PubMed ID: 12447312
[TBL] [Abstract][Full Text] [Related]
25. Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China.
Qun W; Tao Y
Hepatogastroenterology; 2010; 57(99-100):426-9. PubMed ID: 20698202
[TBL] [Abstract][Full Text] [Related]
26. Proximal biliary tumors.
Brown KM; Geller DA
Surg Clin North Am; 2014 Apr; 94(2):311-23. PubMed ID: 24679423
[TBL] [Abstract][Full Text] [Related]
27. Recurrent biliary dissemination of colon cancer liver metastasis: a case report.
Onishi I; Kayahara M; Takei R; Makita N; Munemoto M; Yagi Y; Kawashima A
J Med Case Rep; 2018 Oct; 12(1):314. PubMed ID: 30367665
[TBL] [Abstract][Full Text] [Related]
28. PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature.
Wang Z; Zeng T; Li Y; Zhang D; Yuan Z; Huang M; Yang Y; Zhou W
Front Immunol; 2021; 12():799822. PubMed ID: 35003124
[TBL] [Abstract][Full Text] [Related]
29. [A case of surgical resection of a combined hepatocellular and cholangiocarcinoma after transarterial chemoembolization].
Yakoshi Y; Toyoki Y; Ishido K; Kudo D; Kimura N; Wakiya T; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1798-800. PubMed ID: 24393926
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic ultrasound-guided hepaticogastrostomy for advanced cholangiocarcinoma after failed stenting by endoscopic retrograde cholangiopancreatography.
Panpimanmas S; Ratanachu-ek T
Asian J Surg; 2013 Oct; 36(4):154-8. PubMed ID: 23768731
[TBL] [Abstract][Full Text] [Related]
31. Intrahepatic Carcinosarcoma With Cholangiocarcinoma Elements and Prominent Bile Duct Spread.
Usui G; Hashimoto H; Kusakabe M; Shirota G; Sugiura Y; Fujita Y; Satou S; Harihara Y; Horiuchi H; Morikawa T
Int J Surg Pathol; 2019 Dec; 27(8):900-906. PubMed ID: 31203684
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
[TBL] [Abstract][Full Text] [Related]
33. Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden.
Gbolahan O; Hashemi-Sadraei N; O'Neil B
J Natl Compr Canc Netw; 2019 Jun; 17(6):644-648. PubMed ID: 31200359
[TBL] [Abstract][Full Text] [Related]
34. [A Case of Unresectable Hilar Cholangiocarcinoma Resected Curatively Through Effective Response to Neoadjuvant Chemotherapy].
Imafuji H; Matsuo Y; Aoyama Y; Kato T; Omi K; Hayashi Y; Saito K; Tsuboi K; Morimoto M; Ogawa R; Takahashi H; Yoshida M; Naitoh I; Hayashi K; Takiguchi S
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1268-1270. PubMed ID: 32829371
[TBL] [Abstract][Full Text] [Related]
35. Response to Capmatinib in a MET Fusion-positive Cholangiocarcinoma.
Turpin A; Descarpentries C; Grégoire V; Farchi O; Cortot AB; Jamme P
Oncologist; 2023 Jan; 28(1):80-83. PubMed ID: 36434677
[TBL] [Abstract][Full Text] [Related]
36. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings.
Han JK; Choi BI; Kim AY; An SK; Lee JW; Kim TK; Kim SW
Radiographics; 2002; 22(1):173-87. PubMed ID: 11796906
[TBL] [Abstract][Full Text] [Related]
37. Resection of a hilar cholangiocarcinoma in a patient with absent portal bifurcation.
Yamamoto H; Nagino M; Kawabata Y; Maki A; Takenouchi Y; Iwahashi N; Hayakawa N; Nimura Y
Hepatogastroenterology; 2000; 47(32):362-4. PubMed ID: 10791190
[TBL] [Abstract][Full Text] [Related]
38. Hilar cholangiocarcinoma accompanied by pancreaticobiliary maljunction without bile duct dilatation 20 years after cholecystectomy: report of a case.
Yamada S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Kanamoto M; Hanaoka J; Iwahashi S; Saito Y; Ishibashi H
J Med Invest; 2013; 60(1-2):169-73. PubMed ID: 23614928
[TBL] [Abstract][Full Text] [Related]
39. [Radiological staging of hilar cholangiocarcinoma].
Byun JH
Korean J Gastroenterol; 2005 Jul; 46(1):7-15. PubMed ID: 16030398
[TBL] [Abstract][Full Text] [Related]
40. Three-dimensional computed tomographic cholangiography as a novel diagnostic tool for evaluation of bile duct invasion of perihilar cholangiocarcinoma.
Ajiki T; Fukumoto T; Ueno K; Okazaki T; Matsumoto I; Ku Y
Hepatogastroenterology; 2013; 60(128):1833-8. PubMed ID: 24719915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
